Lung Endothelial Cell Apoptosis and Emphysema

肺内皮细胞凋亡与肺气肿

基本信息

项目摘要

DESCRIPTION (provided by applicant): Cigarette smoke (CS) is the primary cause of COPD, the fourth leading cause of death in the US. CS-induced oxidant stress causes endothelial cell (EC) apoptosis, and there is growing evidence that apoptosis of alveolar wall cells plays a role in the development of emphysema. The overall objective of this proposal is to understand mechanisms of CS-induced lung EC apoptosis and emphysema. Our previous studies on carboxylmethylation of small GTPases indicated that inhibition of RhoA GTPase activity causes focal adhesion complex (FAC) disruption and lung EC apoptosis. We present preliminary data indicating that CS extract (CSE) disrupts FAC via oxidative stress, causes EC apoptosis, and decreases RhoA activity. Aim 1: We will determine if oxidant- mediated RhoA inactivation causes CSE-induced loss of FAC and apoptosis of pulmonary EC. Our previous studies also demonstrated that EC apoptosis occurs despite activation of the unfolded protein response (UPR) when ER molecular chaperones are decreased. Our preliminary data indicate that CSE activates a UPR component, eIF2a, which was also activated in emphysematous lungs of mice exposed to CS. Aim 2: We will determine if UPR is first activated upon CSE exposure and ultimately defective after prolonged oxidative stress in pulmonary EC. Autophagy is a protective process, markers of which have been demonstrated in lungs of COPD patients. Our preliminary data demonstrate increased expression of autophagy markers in lung endothelial cells exposed to CSE and in lungs of mice exposed to CS. Aim 3: We will determine if autophagy is activated upon CSE exposure and ultimately defective after prolonged oxidative stress in pulmonary EC. The proposed studies will enhance understanding of the pathogenesis of emphysema and may result in develop of new therapeutic approaches to this devastating disease. PUBLIC HEALTH RELEVANCE: Chronic Obstructive Pulmonary Disease (COPD) is the fourth most common diagnosis of hospitalized veterans, accounting for about 33% of all primary or secondary discharge diagnoses. Tobacco use, the most common cause of COPD, is also very common among veterans with a prevalence of 34% (compared to 22% for civilians). Thus, tobacco-induced COPD is a very costly cause of morbidity among veterans in terms of both healthcare costs and suffering. Furthermore, COPD is an important co-morbidity for other common p0roblems among veterans, such as lung cancer and atherosclerosis. Thus, it is very important to understand the mechanism of tobacco-induced lung disease. The studies proposed in this application are directly relevant to veterans' health in that these studies will determine the mechanism of injury to the lung vascular endothelium caused by tobacco and the role that this plays in development of COPD. These studies may result in development of more effective treatments for COPD.
描述(由申请人提供): 吸烟(CS)是COPD的主要原因,是美国第四大死亡原因。CS诱导的氧化应激导致内皮细胞(EC)凋亡,越来越多的证据表明肺泡壁细胞凋亡在肺气肿的发生发展中起作用。本研究的总体目标是了解CS诱导肺EC凋亡和肺气肿的机制。我们以前对小GTP酶羧甲基化的研究表明,RhoA GTP酶活性的抑制导致粘着斑复合物(FAC)的破坏和肺EC凋亡。我们目前的初步数据表明,CS提取物(CSE)通过氧化应激破坏FAC,导致EC凋亡,并降低RhoA活性。目的1:我们将确定氧化剂介导的RhoA失活是否导致CSE诱导的FAC丧失和肺EC凋亡。我们以前的研究也表明,当ER分子伴侣减少时,尽管未折叠蛋白反应(UPR)被激活,EC凋亡也会发生。我们的初步数据表明,CSE激活UPR组分eIF2a,其在暴露于CS的小鼠的肺气肿肺中也被激活。目的2:我们将确定UPR是否在CSE暴露后首先被激活,并在肺EC中长期氧化应激后最终有缺陷。自噬是一种保护性过程,其标志物已在COPD患者的肺中得到证实。我们的初步数据表明,暴露于CSE的肺内皮细胞和暴露于CS的小鼠肺中自噬标志物的表达增加。目的3:我们将确定自噬是否在CSE暴露后被激活,并在肺EC中长期氧化应激后最终有缺陷。这些研究将加深对肺气肿发病机制的理解,并可能导致这种毁灭性疾病的新治疗方法的发展。 公共卫生关系: 慢性阻塞性肺疾病(COPD)是住院退伍军人的第四大常见诊断,约占所有主要或次要出院诊断的33%。吸烟是COPD最常见的原因,在退伍军人中也很常见,患病率为34%(平民为22%)。因此,烟草诱导的COPD是退伍军人中在医疗保健成本和痛苦方面非常昂贵的发病原因。此外,COPD是退伍军人中其他常见疾病(如肺癌和动脉粥样硬化)的重要合并症。因此,了解烟草引起的肺部疾病的机制是非常重要的。本申请中提出的研究与退伍军人的健康直接相关,因为这些研究将确定由烟草引起的肺血管内皮损伤的机制及其在COPD发展中的作用。这些研究可能导致开发更有效的COPD治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sharon Irene Smith Rounds其他文献

Sharon Irene Smith Rounds的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sharon Irene Smith Rounds', 18)}}的其他基金

RI-Center for Clinical and Translational Science
RI-临床和转化科学中心
  • 批准号:
    10413517
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
  • 批准号:
    10468390
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
  • 批准号:
    10681738
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Pilot Projects Program
试点项目计划
  • 批准号:
    10281528
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
RI-Center for Clinical and Translational Science
RI-临床和转化科学中心
  • 批准号:
    10403751
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
  • 批准号:
    10595415
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
  • 批准号:
    10281523
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Pilot Projects Program
试点项目计划
  • 批准号:
    8948616
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
  • 批准号:
    10466949
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Pilot Projects Program
试点项目计划
  • 批准号:
    10466954
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了